ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Plasma Proteins Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-24D2458
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Plasma Proteins Market Insights Forecast to 2028
BUY CHAPTERS

Global Recombinant Plasma Proteins Market Insights, Forecast to 2030

Code: QYRE-Auto-24D2458
Report
December 2024
Pages:92
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Limited
Shire (Takeda Pharmaceutical Company Limited)
Octapharma AG
Novo Nordisk
Bayer
Bioverativ Therapeutics, Inc. (Sanofi)
Aptevo Therapeutics
Pharming Group
Pfizer Inc

Recombinant Plasma Proteins Market Size

The global Recombinant Plasma Proteins market is projected to grow from US$ 94 million in 2024 to US$ 106.4 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.1% during the forecast period.

Recombinant Plasma Proteins Market

Recombinant Plasma Proteins Market

For almost 50 years, the fractionation of human plasma has been the sole possible source of a wide range of therapeutic proteins--such as coagulation factors, anticoagulants, immunoglobulins, and albumin--essential to the treatment of serious congenital or acquired bleeding or immunological diseases. In the last 20 years, the application of recombinant technologies to mammalian cell cultures has made possible--although with some limitations in productivity, costs, and immunogenic risks-
Market Analysis and Insights: Global Recombinant Plasma Proteins Market
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Covers:
This report presents an overview of global market for Recombinant Plasma Proteins market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Recombinant Plasma Proteins, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Recombinant Plasma Proteins, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Recombinant Plasma Proteins revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Recombinant Plasma Proteins market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Recombinant Plasma Proteins revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Recombinant Plasma Proteins Market Report

Report Metric Details
Report Name Recombinant Plasma Proteins Market
Accounted market size in 2024 US$ 94 million
Forecasted market size in 2030 US$ 106.4 million
Base Year 2024
Forecasted years 2025 - 2030
Segment by Type
  • Chinese Hamster Ovary (CHO) Cell Line
  • Baby Hamster Kidney (BHK) Cell Line
  • Human Embryonic Kidney (HEK) Cell Line
  • Others
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company CSL Limited, Shire (Takeda Pharmaceutical Company Limited), Octapharma, Novo Nordisk, Bayer, Bioverativ Therapeutics, Inc. (Sanofi), Aptevo Therapeutics, Pharming Group, Pfizer
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Recombinant Plasma Proteins in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Recombinant Plasma Proteins companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Plasma Proteins revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

What is the Recombinant Plasma Proteins Market size in 2030?

Ans: The Recombinant Plasma Proteins Market size in 2030 will be US$ 106.4 million.

Who are the main players in the Recombinant Plasma Proteins Market report?

Ans: The main players in the Recombinant Plasma Proteins Market are CSL Limited, Shire (Takeda Pharmaceutical Company Limited), Octapharma, Novo Nordisk, Bayer, Bioverativ Therapeutics, Inc. (Sanofi), Aptevo Therapeutics, Pharming Group, Pfizer

What are the Application segmentation covered in the Recombinant Plasma Proteins Market report?

Ans: The Applications covered in the Recombinant Plasma Proteins Market report are Hemophilia A, Hemophilia B, Von Willebrand Disease, Others

What are the Type segmentation covered in the Recombinant Plasma Proteins Market report?

Ans: The Types covered in the Recombinant Plasma Proteins Market report are Chinese Hamster Ovary (CHO) Cell Line, Baby Hamster Kidney (BHK) Cell Line, Human Embryonic Kidney (HEK) Cell Line, Others

Recommended Reports

Recombinant Protein Markets

Plasma and Derivatives

Coagulation and Therapy

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Recombinant Plasma Proteins Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Chinese Hamster Ovary (CHO) Cell Line
1.2.3 Baby Hamster Kidney (BHK) Cell Line
1.2.4 Human Embryonic Kidney (HEK) Cell Line
1.2.5 Others
1.3 Market by Application
1.3.1 Global Recombinant Plasma Proteins Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hemophilia A
1.3.3 Hemophilia B
1.3.4 Von Willebrand Disease
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Recombinant Plasma Proteins Market Perspective (2019-2030)
2.2 Global Recombinant Plasma Proteins Growth Trends by Region
2.2.1 Recombinant Plasma Proteins Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Recombinant Plasma Proteins Historic Market Size by Region (2019-2024)
2.2.3 Recombinant Plasma Proteins Forecasted Market Size by Region (2025-2030)
2.3 Recombinant Plasma Proteins Market Dynamics
2.3.1 Recombinant Plasma Proteins Industry Trends
2.3.2 Recombinant Plasma Proteins Market Drivers
2.3.3 Recombinant Plasma Proteins Market Challenges
2.3.4 Recombinant Plasma Proteins Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Recombinant Plasma Proteins by Players
3.1.1 Global Recombinant Plasma Proteins Revenue by Players (2019-2024)
3.1.2 Global Recombinant Plasma Proteins Revenue Market Share by Players (2019-2024)
3.2 Global Recombinant Plasma Proteins Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Recombinant Plasma Proteins, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Recombinant Plasma Proteins Market Concentration Ratio
3.4.1 Global Recombinant Plasma Proteins Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Recombinant Plasma Proteins Revenue in 2023
3.5 Global Key Players of Recombinant Plasma Proteins Head office and Area Served
3.6 Global Key Players of Recombinant Plasma Proteins, Product and Application
3.7 Global Key Players of Recombinant Plasma Proteins, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Recombinant Plasma Proteins Breakdown Data by Type
4.1 Global Recombinant Plasma Proteins Historic Market Size by Type (2019-2024)
4.2 Global Recombinant Plasma Proteins Forecasted Market Size by Type (2025-2030)
5 Recombinant Plasma Proteins Breakdown Data by Application
5.1 Global Recombinant Plasma Proteins Historic Market Size by Application (2019-2024)
5.2 Global Recombinant Plasma Proteins Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Recombinant Plasma Proteins Market Size (2019-2030)
6.2 North America Recombinant Plasma Proteins Market Size by Type
6.2.1 North America Recombinant Plasma Proteins Market Size by Type (2019-2024)
6.2.2 North America Recombinant Plasma Proteins Market Size by Type (2025-2030)
6.2.3 North America Recombinant Plasma Proteins Market Share by Type (2019-2030)
6.3 North America Recombinant Plasma Proteins Market Size by Application
6.3.1 North America Recombinant Plasma Proteins Market Size by Application (2019-2024)
6.3.2 North America Recombinant Plasma Proteins Market Size by Application (2025-2030)
6.3.3 North America Recombinant Plasma Proteins Market Share by Application (2019-2030)
6.4 North America Recombinant Plasma Proteins Market Size by Country
6.4.1 North America Recombinant Plasma Proteins Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Recombinant Plasma Proteins Market Size by Country (2019-2024)
6.4.3 North America Recombinant Plasma Proteins Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Recombinant Plasma Proteins Market Size (2019-2030)
7.2 Europe Recombinant Plasma Proteins Market Size by Type
7.2.1 Europe Recombinant Plasma Proteins Market Size by Type (2019-2024)
7.2.2 Europe Recombinant Plasma Proteins Market Size by Type (2025-2030)
7.2.3 Europe Recombinant Plasma Proteins Market Share by Type (2019-2030)
7.3 Europe Recombinant Plasma Proteins Market Size by Application
7.3.1 Europe Recombinant Plasma Proteins Market Size by Application (2019-2024)
7.3.2 Europe Recombinant Plasma Proteins Market Size by Application (2025-2030)
7.3.3 Europe Recombinant Plasma Proteins Market Share by Application (2019-2030)
7.4 Europe Recombinant Plasma Proteins Market Size by Country
7.4.1 Europe Recombinant Plasma Proteins Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Recombinant Plasma Proteins Market Size by Country (2019-2024)
7.4.3 Europe Recombinant Plasma Proteins Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Recombinant Plasma Proteins Market Size (2019-2030)
8.2 China Recombinant Plasma Proteins Market Size by Type
8.2.1 China Recombinant Plasma Proteins Market Size by Type (2019-2024)
8.2.2 China Recombinant Plasma Proteins Market Size by Type (2025-2030)
8.2.3 China Recombinant Plasma Proteins Market Share by Type (2019-2030)
8.3 China Recombinant Plasma Proteins Market Size by Application
8.3.1 China Recombinant Plasma Proteins Market Size by Application (2019-2024)
8.3.2 China Recombinant Plasma Proteins Market Size by Application (2025-2030)
8.3.3 China Recombinant Plasma Proteins Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Recombinant Plasma Proteins Market Size (2019-2030)
9.2 Asia Recombinant Plasma Proteins Market Size by Type
9.2.1 Asia Recombinant Plasma Proteins Market Size by Type (2019-2024)
9.2.2 Asia Recombinant Plasma Proteins Market Size by Type (2025-2030)
9.2.3 Asia Recombinant Plasma Proteins Market Share by Type (2019-2030)
9.3 Asia Recombinant Plasma Proteins Market Size by Application
9.3.1 Asia Recombinant Plasma Proteins Market Size by Application (2019-2024)
9.3.2 Asia Recombinant Plasma Proteins Market Size by Application (2025-2030)
9.3.3 Asia Recombinant Plasma Proteins Market Share by Application (2019-2030)
9.4 Asia Recombinant Plasma Proteins Market Size by Region
9.4.1 Asia Recombinant Plasma Proteins Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Recombinant Plasma Proteins Market Size by Region (2019-2024)
9.4.3 Asia Recombinant Plasma Proteins Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Type
10.2.1 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Application
10.3.1 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Country
10.4.1 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 CSL Limited
11.1.1 CSL Limited Company Details
11.1.2 CSL Limited Business Overview
11.1.3 CSL Limited Recombinant Plasma Proteins Introduction
11.1.4 CSL Limited Revenue in Recombinant Plasma Proteins Business (2019-2024)
11.1.5 CSL Limited Recent Developments
11.2 Shire (Takeda Pharmaceutical Company Limited)
11.2.1 Shire (Takeda Pharmaceutical Company Limited) Company Details
11.2.2 Shire (Takeda Pharmaceutical Company Limited) Business Overview
11.2.3 Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Introduction
11.2.4 Shire (Takeda Pharmaceutical Company Limited) Revenue in Recombinant Plasma Proteins Business (2019-2024)
11.2.5 Shire (Takeda Pharmaceutical Company Limited) Recent Developments
11.3 Octapharma
11.3.1 Octapharma Company Details
11.3.2 Octapharma Business Overview
11.3.3 Octapharma Recombinant Plasma Proteins Introduction
11.3.4 Octapharma Revenue in Recombinant Plasma Proteins Business (2019-2024)
11.3.5 Octapharma Recent Developments
11.4 Novo Nordisk
11.4.1 Novo Nordisk Company Details
11.4.2 Novo Nordisk Business Overview
11.4.3 Novo Nordisk Recombinant Plasma Proteins Introduction
11.4.4 Novo Nordisk Revenue in Recombinant Plasma Proteins Business (2019-2024)
11.4.5 Novo Nordisk Recent Developments
11.5 Bayer
11.5.1 Bayer Company Details
11.5.2 Bayer Business Overview
11.5.3 Bayer Recombinant Plasma Proteins Introduction
11.5.4 Bayer Revenue in Recombinant Plasma Proteins Business (2019-2024)
11.5.5 Bayer Recent Developments
11.6 Bioverativ Therapeutics, Inc. (Sanofi)
11.6.1 Bioverativ Therapeutics, Inc. (Sanofi) Company Details
11.6.2 Bioverativ Therapeutics, Inc. (Sanofi) Business Overview
11.6.3 Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Introduction
11.6.4 Bioverativ Therapeutics, Inc. (Sanofi) Revenue in Recombinant Plasma Proteins Business (2019-2024)
11.6.5 Bioverativ Therapeutics, Inc. (Sanofi) Recent Developments
11.7 Aptevo Therapeutics
11.7.1 Aptevo Therapeutics Company Details
11.7.2 Aptevo Therapeutics Business Overview
11.7.3 Aptevo Therapeutics Recombinant Plasma Proteins Introduction
11.7.4 Aptevo Therapeutics Revenue in Recombinant Plasma Proteins Business (2019-2024)
11.7.5 Aptevo Therapeutics Recent Developments
11.8 Pharming Group
11.8.1 Pharming Group Company Details
11.8.2 Pharming Group Business Overview
11.8.3 Pharming Group Recombinant Plasma Proteins Introduction
11.8.4 Pharming Group Revenue in Recombinant Plasma Proteins Business (2019-2024)
11.8.5 Pharming Group Recent Developments
11.9 Pfizer
11.9.1 Pfizer Company Details
11.9.2 Pfizer Business Overview
11.9.3 Pfizer Recombinant Plasma Proteins Introduction
11.9.4 Pfizer Revenue in Recombinant Plasma Proteins Business (2019-2024)
11.9.5 Pfizer Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
CSL Limited
Shire (Takeda Pharmaceutical Company Limited)
Octapharma AG
Novo Nordisk
Bayer
Bioverativ Therapeutics, Inc. (Sanofi)
Aptevo Therapeutics
Pharming Group
Pfizer Inc
List of Tables
    Table 1. Global Recombinant Plasma Proteins Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Chinese Hamster Ovary (CHO) Cell Line
    Table 3. Key Players of Baby Hamster Kidney (BHK) Cell Line
    Table 4. Key Players of Human Embryonic Kidney (HEK) Cell Line
    Table 5. Key Players of Others
    Table 6. Global Recombinant Plasma Proteins Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Recombinant Plasma Proteins Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Recombinant Plasma Proteins Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Recombinant Plasma Proteins Market Share by Region (2019-2024)
    Table 10. Global Recombinant Plasma Proteins Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Recombinant Plasma Proteins Market Share by Region (2025-2030)
    Table 12. Recombinant Plasma Proteins Market Trends
    Table 13. Recombinant Plasma Proteins Market Drivers
    Table 14. Recombinant Plasma Proteins Market Challenges
    Table 15. Recombinant Plasma Proteins Market Restraints
    Table 16. Global Recombinant Plasma Proteins Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Recombinant Plasma Proteins Revenue Share by Players (2019-2024)
    Table 18. Global Top Recombinant Plasma Proteins by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Plasma Proteins as of 2023)
    Table 19. Global Recombinant Plasma Proteins Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Recombinant Plasma Proteins Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Recombinant Plasma Proteins, Headquarters and Area Served
    Table 22. Global Key Players of Recombinant Plasma Proteins, Product and Application
    Table 23. Global Key Players of Recombinant Plasma Proteins, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Recombinant Plasma Proteins Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Recombinant Plasma Proteins Revenue Market Share by Type (2019-2024)
    Table 27. Global Recombinant Plasma Proteins Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Recombinant Plasma Proteins Revenue Market Share by Type (2025-2030)
    Table 29. Global Recombinant Plasma Proteins Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Recombinant Plasma Proteins Revenue Share by Application (2019-2024)
    Table 31. Global Recombinant Plasma Proteins Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Recombinant Plasma Proteins Revenue Share by Application (2025-2030)
    Table 33. North America Recombinant Plasma Proteins Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Recombinant Plasma Proteins Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Recombinant Plasma Proteins Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Recombinant Plasma Proteins Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Recombinant Plasma Proteins Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Recombinant Plasma Proteins Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Recombinant Plasma Proteins Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Recombinant Plasma Proteins Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Recombinant Plasma Proteins Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Recombinant Plasma Proteins Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Recombinant Plasma Proteins Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Recombinant Plasma Proteins Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Recombinant Plasma Proteins Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Recombinant Plasma Proteins Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Recombinant Plasma Proteins Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Recombinant Plasma Proteins Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Recombinant Plasma Proteins Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Recombinant Plasma Proteins Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Recombinant Plasma Proteins Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Recombinant Plasma Proteins Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Recombinant Plasma Proteins Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Recombinant Plasma Proteins Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Recombinant Plasma Proteins Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Recombinant Plasma Proteins Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Recombinant Plasma Proteins Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Recombinant Plasma Proteins Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size by Country (2025-2030) & (US$ Million)
    Table 65. CSL Limited Company Details
    Table 66. CSL Limited Business Overview
    Table 67. CSL Limited Recombinant Plasma Proteins Product
    Table 68. CSL Limited Revenue in Recombinant Plasma Proteins Business (2019-2024) & (US$ Million)
    Table 69. CSL Limited Recent Developments
    Table 70. Shire (Takeda Pharmaceutical Company Limited) Company Details
    Table 71. Shire (Takeda Pharmaceutical Company Limited) Business Overview
    Table 72. Shire (Takeda Pharmaceutical Company Limited) Recombinant Plasma Proteins Product
    Table 73. Shire (Takeda Pharmaceutical Company Limited) Revenue in Recombinant Plasma Proteins Business (2019-2024) & (US$ Million)
    Table 74. Shire (Takeda Pharmaceutical Company Limited) Recent Developments
    Table 75. Octapharma Company Details
    Table 76. Octapharma Business Overview
    Table 77. Octapharma Recombinant Plasma Proteins Product
    Table 78. Octapharma Revenue in Recombinant Plasma Proteins Business (2019-2024) & (US$ Million)
    Table 79. Octapharma Recent Developments
    Table 80. Novo Nordisk Company Details
    Table 81. Novo Nordisk Business Overview
    Table 82. Novo Nordisk Recombinant Plasma Proteins Product
    Table 83. Novo Nordisk Revenue in Recombinant Plasma Proteins Business (2019-2024) & (US$ Million)
    Table 84. Novo Nordisk Recent Developments
    Table 85. Bayer Company Details
    Table 86. Bayer Business Overview
    Table 87. Bayer Recombinant Plasma Proteins Product
    Table 88. Bayer Revenue in Recombinant Plasma Proteins Business (2019-2024) & (US$ Million)
    Table 89. Bayer Recent Developments
    Table 90. Bioverativ Therapeutics, Inc. (Sanofi) Company Details
    Table 91. Bioverativ Therapeutics, Inc. (Sanofi) Business Overview
    Table 92. Bioverativ Therapeutics, Inc. (Sanofi) Recombinant Plasma Proteins Product
    Table 93. Bioverativ Therapeutics, Inc. (Sanofi) Revenue in Recombinant Plasma Proteins Business (2019-2024) & (US$ Million)
    Table 94. Bioverativ Therapeutics, Inc. (Sanofi) Recent Developments
    Table 95. Aptevo Therapeutics Company Details
    Table 96. Aptevo Therapeutics Business Overview
    Table 97. Aptevo Therapeutics Recombinant Plasma Proteins Product
    Table 98. Aptevo Therapeutics Revenue in Recombinant Plasma Proteins Business (2019-2024) & (US$ Million)
    Table 99. Aptevo Therapeutics Recent Developments
    Table 100. Pharming Group Company Details
    Table 101. Pharming Group Business Overview
    Table 102. Pharming Group Recombinant Plasma Proteins Product
    Table 103. Pharming Group Revenue in Recombinant Plasma Proteins Business (2019-2024) & (US$ Million)
    Table 104. Pharming Group Recent Developments
    Table 105. Pfizer Company Details
    Table 106. Pfizer Business Overview
    Table 107. Pfizer Recombinant Plasma Proteins Product
    Table 108. Pfizer Revenue in Recombinant Plasma Proteins Business (2019-2024) & (US$ Million)
    Table 109. Pfizer Recent Developments
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Recombinant Plasma Proteins Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Recombinant Plasma Proteins Market Share by Type: 2023 VS 2030
    Figure 3. Chinese Hamster Ovary (CHO) Cell Line Features
    Figure 4. Baby Hamster Kidney (BHK) Cell Line Features
    Figure 5. Human Embryonic Kidney (HEK) Cell Line Features
    Figure 6. Others Features
    Figure 7. Global Recombinant Plasma Proteins Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Recombinant Plasma Proteins Market Share by Application: 2023 VS 2030
    Figure 9. Hemophilia A Case Studies
    Figure 10. Hemophilia B Case Studies
    Figure 11. Von Willebrand Disease Case Studies
    Figure 12. Others Case Studies
    Figure 13. Recombinant Plasma Proteins Report Years Considered
    Figure 14. Global Recombinant Plasma Proteins Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Recombinant Plasma Proteins Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Recombinant Plasma Proteins Market Share by Region: 2023 VS 2030
    Figure 17. Global Recombinant Plasma Proteins Market Share by Players in 2023
    Figure 18. Global Top Recombinant Plasma Proteins Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Plasma Proteins as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Recombinant Plasma Proteins Revenue in 2023
    Figure 20. North America Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Recombinant Plasma Proteins Market Share by Type (2019-2030)
    Figure 22. North America Recombinant Plasma Proteins Market Share by Application (2019-2030)
    Figure 23. North America Recombinant Plasma Proteins Market Share by Country (2019-2030)
    Figure 24. United States Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Recombinant Plasma Proteins Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Recombinant Plasma Proteins Market Share by Type (2019-2030)
    Figure 28. Europe Recombinant Plasma Proteins Market Share by Application (2019-2030)
    Figure 29. Europe Recombinant Plasma Proteins Market Share by Country (2019-2030)
    Figure 30. Germany Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Recombinant Plasma Proteins Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Recombinant Plasma Proteins Market Share by Type (2019-2030)
    Figure 38. China Recombinant Plasma Proteins Market Share by Application (2019-2030)
    Figure 39. Asia Recombinant Plasma Proteins Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Recombinant Plasma Proteins Market Share by Type (2019-2030)
    Figure 41. Asia Recombinant Plasma Proteins Market Share by Application (2019-2030)
    Figure 42. Asia Recombinant Plasma Proteins Market Share by Region (2019-2030)
    Figure 43. Japan Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Recombinant Plasma Proteins Market Share by Country (2019-2030)
    Figure 53. Brazil Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Recombinant Plasma Proteins Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. CSL Limited Revenue Growth Rate in Recombinant Plasma Proteins Business (2019-2024)
    Figure 60. Shire (Takeda Pharmaceutical Company Limited) Revenue Growth Rate in Recombinant Plasma Proteins Business (2019-2024)
    Figure 61. Octapharma Revenue Growth Rate in Recombinant Plasma Proteins Business (2019-2024)
    Figure 62. Novo Nordisk Revenue Growth Rate in Recombinant Plasma Proteins Business (2019-2024)
    Figure 63. Bayer Revenue Growth Rate in Recombinant Plasma Proteins Business (2019-2024)
    Figure 64. Bioverativ Therapeutics, Inc. (Sanofi) Revenue Growth Rate in Recombinant Plasma Proteins Business (2019-2024)
    Figure 65. Aptevo Therapeutics Revenue Growth Rate in Recombinant Plasma Proteins Business (2019-2024)
    Figure 66. Pharming Group Revenue Growth Rate in Recombinant Plasma Proteins Business (2019-2024)
    Figure 67. Pfizer Revenue Growth Rate in Recombinant Plasma Proteins Business (2019-2024)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Recombinant Plasma Protein Therapeutics Market Insights Forecast to 2030
Global Plasma Protein Systems Market Research Report 2024
Global Plasma Protein Products Market Research Report 2024
Global Recombinant Cell Culture Supplements Market Insights Forecast to 2030
Global Recombinant Coagulation Factors Market Insights Forecast to 2030
Global Recombinant Human Serum Albumin Test Market Insights Forecast to 2030
Recombinant Protein Therapeutics Market
Global Plasma Protein Therapeutics Market Research Report 2025
Global Recombinant Protein Vaccine Market Insights Forecast to 2030
Blood Plasma Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Therapeutic Recombinant Protein Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Plasma Fractionation Technology Market Research Report 2025
Global Recombinant Therapeutic Protein Market Research Report 2025
Global Human Plasma Protein Products Market Research Report 2024
Global Blood Plasma Fractionation Technology Market Research Report 2025
Global Human Blood Plasma Fractionation Market Research Report 2025
Global Coagulase Plasma Market Research Report 2025
Global Plasma Fractionation Market Research Report 2025
Global Blood Plasma Fractionation Market Research Report 2025
Global Plasma derived Medical Product Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions